All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

Publication year:
General domain:
Specific domain:

  1. A quadrivalent vaccine against serogroup B meningococcal disease: a cost-effectiveness study

    KCE Reports 231 (2014)

    https://kce.fgov.be/en/a-quadrivalent-vaccine-against-serogroup-b-meningococcal-disease-a-cost-effectiveness-study

  2. Machine perfusion in kidneys from deceased donors – A rapid assessment

    KCE Reports 217 (2014)

    https://kce.fgov.be/en/machine-perfusion-in-kidneys-from-deceased-donors-%E2%80%93-a-rapid-assessment

  3. Seasonal influenza vaccination: prioritizing children or other target groups? - Part II

    KCE Reports 204 (2013)

    https://kce.fgov.be/en/seasonal-influenza-vaccination-prioritizing-children-or-other-target-groups-part-ii

  4. Manual for cost-based pricing of hospital interventions

    KCE Reports 178 (2012)

    https://kce.fgov.be/en/manual-for-cost-based-pricing-of-hospital-interventions

  5. Home Oxygen Therapy

    KCE Reports 156 (2011) People suffering from chronic lung diseases need sometimes an oxygen complement at the house. In Belgium, this treatment can be prescribed without restriction by any doctor and one notes a clear increase in the expenditure these last years. Several authorities of decisions are implied in the organization of oxygen treatment, just like of the professional bodies or deprived, and there is a lack of integrated approach.

    https://kce.fgov.be/en/home-oxygen-therapy

  6. Organisation and financing of chronic dialysis in Belgium

    KCE Reports 124 (2010)

    https://kce.fgov.be/en/organisation-and-financing-of-chronic-dialysis-in-belgium

  7. Use of point-of care devices in patients with oral anticoagulation : a Health Technology Assessment

    KCE Reports 117 (2009)

    https://kce.fgov.be/en/use-of-point-of-care-devices-in-patients-with-oral-anticoagulation-a-health-technology-assessment

  8. [Magnetic Resonance Imaging: cost analysis]

    KCE Reports 106 (2009)

    https://kce.fgov.be/en/magnetic-resonance-imaging-cost-analysis

  9. Robot-assisted surgery: health technology assessment

    KCE Reports 104 (2009)

    https://kce.fgov.be/en/robot-assisted-surgery-health-technology-assessment

  10. [Video registration of endoscopic surgery: a rapid assessment]

    KCE Reports 101 (2008)

    https://kce.fgov.be/en/video-registration-of-endoscopic-surgery-a-rapid-assessment

  11. Hearing aids in Belgium: health technology assessment

    KCE Reports 91 (2008)

    https://kce.fgov.be/en/hearing-aids-in-belgium-health-technology-assessment

  12. [Hadrontherapy]

    KCE Reports 67 (2007)

    https://kce.fgov.be/en/hadrontherapy

  13. Drug Eluting Stents in Belgium: Health Technology Assessment

    KCE Reports 66 (2007)

    https://kce.fgov.be/en/drug-eluting-stents-in-belgium-health-technology-assessment

  14. HPV Vaccination for the Prevention of Cervical Cancer in Belgium: Health Technology Assessment

    KCE Reports 64 (2007)

    https://kce.fgov.be/en/hpv-vaccination-for-the-prevention-of-cervical-cancer-in-belgium-health-technology-assessment

  15. [Home Monitoring of Infants in Prevention of Sudden Infant Death Syndrome]

    KCE Reports 46 (2006)

    https://kce.fgov.be/en/home-monitoring-of-infants-in-prevention-of-sudden-infant-death-syndrome

  16. [Screening for Colorectal Cancer : current evidence and budget impact for Belgium.]

    KCE Reports 45 (2006)

    https://kce.fgov.be/en/screening-for-colorectal-cancer-current-evidence-and-budget-impact-for-belgium

  17. [Elective endovascular treatment of the abdominal aortic aneurysm (AAA)]

    KCE Reports 23 (2005)

    https://kce.fgov.be/en/elective-endovascular-treatment-of-the-abdominal-aortic-aneurysm-aaa

  18. Autologous breast reconstruction techniques after mammary resection: time measurements for a potential reevaluation of the surgeon fee

    KCE Reports 251 (2015)

    https://kce.fgov.be/en/autologous-breast-reconstruction-techniques-after-mammary-resection-time-measurements-for-a
  19. Senior couple on contry bike

    Statins for the primary prevention of cardiovascular events

    KCE Reports 306 (2019) A healthy lifestyle remains the most effective way of avoiding cardiovascular diseases and their consequences. Yet since 2002, the annual number of people who use cholesterol-lowering drugs from the statin family increased from 400,000 to 1,500,000. Currently, 25% of the population aged 40 and above take these drugs. Despite decreases in price due to the fact that all statins now exist in generic form, their total cost still stands at 160 million euros annually.

    https://kce.fgov.be/en/statins-for-the-primary-prevention-of-cardiovascular-events
  20. Children in a playground

    Cost-effectiveness analysis of HPV vaccination of boys in Belgium

    KCE Reports 308 (2019) The vaccine for the human papilloma virus (HPV) which causes cervical cancer was introduced about ten years ago in Belgium, but only girls benefit from it. However, it is now established that this same virus is also involved in other cancers, including throat cancer. The recommendations have thus been reviewed and here, as in most western countries, it is now recommended to vaccinate boys too.

    https://kce.fgov.be/en/cost-effectiveness-analysis-of-hpv-vaccination-of-boys-in-belgium